Medication Assisted Treatment in Opioid Use Disorder: Muhamad Aly Rifai, MD

Medication Assisted Treatment in Opioid Use Disorder: Muhamad Aly Rifai, MD

Mental Health News Radio

Muhamad Aly Rifai, MD, CPE, FACP, FAPM, FAPA; a seasoned world-renowned physician executive, with more than 15 years of clinical and leadership experience. I am currently in clinical practice in the Greater Lehigh Valley in Pennsylvania, and engaged...

informativechallenginghopeful

44:4223 Mar 2017

RSS Feed

Medication Assisted Treatment in Opioid Recovery

Episode Overview

  • Medication Assisted Treatment (MAT) is controversial.
  • Opioid epidemic requires innovative solutions.
  • Government policy has been lacking in addressing the crisis.
  • MAT offers a promising approach to addiction recovery.
  • Collaboration among treatment communities is essential.
Our patients are looking to us to provide them treatment, support, and tools to maintain abstinence.

In a compelling episode of Mental Health News Radio, host Kristen Sinanta-Walker engages in a deep exploration of Medication Assisted Treatment (MAT) for opioid use disorder with Dr. Muhamad Aly Rifai. Dr. Rifai, a seasoned psychiatrist and internist specializing in addiction medicine, sheds light on the controversial nature of MAT and its potential to address the opioid epidemic ravaging communities across the United States. With a backdrop of increasing overdose rates, Dr.

Rifai emphasizes the urgent need for effective treatment methods. Medication Assisted Treatment, referred to as MAT, involves using medications to aid in the recovery process for individuals with opioid use disorder. Despite its proven efficacy, MAT has sparked debate among traditional therapeutic communities accustomed to non-pharmacological approaches such as Alcoholics Anonymous and Narcotics Anonymous. Yet, as Dr.

Rifai points out, the traditional methods often fail to yield sustainable sobriety outcomes, as evidenced by the low success rate of patients remaining abstinent post-treatment. The discourse extends beyond treatment modalities to the role of government policy in combatting the opioid crisis. Dr. Rifai highlights the lack of proactive policy from the White House Office of Drug Policy, illustrating a vacuum in leadership since President Trump's inauguration.

This policy stagnation has left many in the field uncertain about the direction and support for addiction treatment initiatives. Dr. Rifai advocates for collaboration among scientific, treatment, and government communities to develop comprehensive strategies to tackle the epidemic. He shares insights into emerging treatment modalities and innovative approaches being explored in Pennsylvania, where he practices. Dr. Rifai encourages listeners to reach out through his websites for further information and support. The episode concludes with an invitation for Dr.

Rifai to return for more discussions, emphasizing the ongoing need to address addiction treatment challenges in depth. This episode is a rallying call for informed, collaborative action in the face of a national crisis.

Podcast buttons

Do you want to link to this podcast?
Get the buttons here!

More From This Show

The latest episodes from the same podcast.

Related Episodes

Similar episodes from other shows in the catalogue.